KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ENTA
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Enanta Pharmaceuticals stock price down 0.88% on Friday
(Updated on Apr 26, 2024)

Sell candidate since Apr 25, 2024 Loss -0.88% PDF

The Enanta Pharmaceuticals stock price fell by -0.88% on the last day (Friday, 26th Apr 2024) from $12.48 to $12.37. It has now fallen 4 days in a row. During the last trading day the stock fluctuated 3.66% from a day low at $12.20 to a day high of $12.65. The price has fallen in 8 of the last 10 days and is down by -24.8% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -9 thousand shares and in total, 66 thousand shares were bought and sold for approximately $812.03 thousand.

Given the current short-term trend, the stock is expected to rise 17.89% during the next 3 months and, with a 90% probability hold a price between $14.58 and $21.64 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ENTA Signals & Forecast

There are few to no technical positive signals at the moment. The Enanta Pharmaceuticals stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $12.99 and $14.99. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, March 28, 2024, and so far it has fallen -29.15%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Enanta Pharmaceuticals stock

Enanta Pharmaceuticals finds support from accumulated volume at $12.36 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.447 between high and low, or 3.66%. For the last week the stock has had daily average volatility of 4.24%.

Enanta Pharmaceuticals is oversold on RSI14 (15). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ENTA) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect Enanta Pharmaceuticals to open at $12.41, and during the day (based on 14 day Average True Range), to move between $11.62 and $13.12, which gives a possible trading interval of +/-$0.752 (+/-6.08%) up or down from last closing price. If Enanta Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 12.16% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $12.36 (0.08%) than the resistance at $13.26 (7.19%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Enanta Pharmaceuticals stock A Buy?

The Enanta Pharmaceuticals stock holds several negative signals and despite the positive trend, we believe Enanta Pharmaceuticals will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -1.376 Sell Candidate Unchanged

Predicted Opening Price for Enanta Pharmaceuticals of Monday, April 29, 2024

Fair opening price April 29, 2024 Current price
$12.41 ( 0.306%) $12.37

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ENTA

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 12.85 3.92 %
R2 12.68 2.54 %
R1 12.58 1.68 %
Current price: 12.37
Support S1 12.24 -1.07 %
S2 12.13 -1.93 %
S3 11.96 -3.30 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 15.35 24.09 %
R2 14.04 13.50 %
R1 13.26 7.19 %
Current price 12.37
Support S1 12.36 -0.0808%
S2 12.34 -0.243%
S3 12.33 -0.323%

FAQ

What is the symbol for Enanta Pharmaceuticals Stock and on which exchange is it traded?
The symbol for Enanta Pharmaceuticals is ENTA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Enanta Pharmaceuticals Stock?
The Enanta Pharmaceuticals stock holds several negative signals and despite the positive trend, we believe Enanta Pharmaceuticals will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Enanta Pharmaceuticals Stock?
Enanta Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Enanta Pharmaceuticals Stock.

What's the current price of Enanta Pharmaceuticals Stock?
As of the end of day on the Apr 26, 2024, the price of an Enanta Pharmaceuticals (ENTA) share was $12.37.

What is the 52-week high and low for Enanta Pharmaceuticals Stock?
The 52-week high for Enanta Pharmaceuticals Stock is $37.75 and the 52-week low is $8.08.

What is the market capitalization of Enanta Pharmaceuticals Stock?
As of the Apr 26, 2024, the market capitalization of Enanta Pharmaceuticals is 264.027M.

When is the next earnings date for Enanta Pharmaceuticals?
The upcoming earnings date for Enanta Pharmaceuticals is May 13, 2024.
Click to get the best stock tips daily for free!

About Enanta Pharmaceuticals

Enanta Pharmaceuticals Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and license agreement with Abbott Laboratories to identify, develop, and commercialize HCV NS3 and NS3/4A pro... ENTA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT